2018PubMedRequires access

[Interleukin-38 expression and clinical significance in serum of patients with chronic obstructive pulmonary disease].

Yingqi Zhu, S P, B Li, Chao-biao Zheng, Jindi Ma

Open publisher page 7 citations

Abstract

IL-38 is compensatory increased in serum of patients with COPD and may be used as one of the serological markers for evaluation of COPD.

About this research paper

What this paper is about

IL-38 is compensatory increased in serum of patients with COPD and may be used as one of the serological markers for evaluation of COPD.

Why it matters

OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

IL-38 is compensatory increased in serum of patients with COPD and may be used as one of the serological markers for evaluation of COPD.

Key concepts: COPD, Medicine, Internal medicine, Gastroenterology, Exacerbation, Rank correlation, Acute exacerbation of chronic obstructive pulmonary disease, Pulmonary disease

Related papers

Back to paper searchBrowse research topicsOriginal source
[Interleukin-38 expression and clinical significance in serum of patients with chronic obstructive pulmonary disease]. — Research Paper | ScholarLens